Get started
Author

Sofia Dahlqvist

Observed names: Dahlqvist, Sofia, S. Dahlqvist, SOFIA DAHLQVIST, Sofia Pekkari
ORCID: 0000-0003-3877-6974
Observed ORCID: 0000-0003-3877-6974
OpenAlex ID: A5049256948
Excess Mortality among Persons with Type 2 Diabetes
2015 · Mauro Tancredi, Annika Rosengren, et al. · New England Journal of Medicine · 1,036
PDF
Glycemic Control and Excess Mortality in Type 1 Diabetes
2014 · Marcus Lind, Ann-Marie Svensson, et al. · New England Journal of Medicine · 995
PDF
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial
2017 · Marcus Lind, William Polonsky, et al. · JAMA · 733
A Clinical Trial of the Accuracy and Treatment Experience of the Flash Glucose Monitor FreeStyle Libre in Adults with Type 1 Diabetes
2017 · Arndís F. Ólafsdóttir, Stig Attvall, et al. · Diabetes Technology & Therapeutics · 180
PDF
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)
2018 · Arndís F. Ólafsdóttir, William Polonsky, et al. · Diabetes Technology & Therapeutics · 116
PDF
Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)
2015 · Marcus Lind, Irl B Hirsch, et al. · BMJ · 87
PDF
A Clinical Trial of the Accuracy and Treatment Experience of the Dexcom G4 Sensor (Dexcom G4 System) and Enlite Sensor (Guardian REAL-Time System) Tested Simultaneously in Ambulatory Patients with Type 1 Diabetes
2014 · Viktorija Matuleviciene, Jeffrey I. Joseph, et al. · Diabetes Technology & Therapeutics · 86
Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study
2017 · Sofia Dahlqvist, Annika Rosengren, et al. · The Lancet Diabetes & Endocrinology · 74
The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)
2020 · Shilan Seyed Ahmadi, Klara Westman, et al. · Diabetes Care · 52
Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI
2020 · Marcus Lind, Arndís F. Ólafsdóttir, et al. · Diabetes Care · 40
Assessing the Accuracy of Continuous Glucose Monitoring (CGM) Calibrated With Capillary Values Using Capillary or Venous Glucose Levels as a Reference
2016 · Mervi Andelin, Jort Kropff, et al. · Journal of Diabetes Science and Technology · 30
PDF
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study)
2016 · Marcus Lind, William Polonsky, et al. · Journal of Diabetes Science and Technology · 27
Predicting the Effectiveness of Insulin Pump Therapy on Glycemic Control in Clinical Practice: A Retrospective Study of Patients with Type 1 Diabetes from 10 Outpatient Diabetes Clinics in Sweden over 5 Years
2014 · Mark Clements, Viktorija Matuleviciene, et al. · Diabetes Technology & Therapeutics · 27
Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)
2018 · Sofia Dahlqvist, Elsa Ahlén, et al. · BMJ Open Diabetes Research & Care · 25
PDF
Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections
2019 · Sheyda Sofizadeh, Henrik Imberg, et al. · Diabetes Therapy · 22
PDF
Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials
2024 · Sofia Sterner Isaksson, Henrik Imberg, et al. · Diabetologia · 19
PDF
Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetes
2018 · Magnus O. Wijkman, Mary Dena, et al. · Journal of Clinical Hypertension · 19
Glycemic Control, Renal Complications, and Current Smoking in Relation to Excess Risk of Mortality in Persons With Type 1 Diabetes
2016 · Elsa Ahlén, Aldina Pivodic, et al. · Journal of Diabetes Science and Technology · 19
Treatment Satisfaction and Well-Being With Continuous Glucose Monitoring in People With Type 1 Diabetes: An Analysis Based on the GOLD Randomized Trial
2023 · Daniel Pylov, William Polonsky, et al. · Journal of Diabetes Science and Technology · 15
PDF
Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI‐liraglutide study 5)
2018 · S. S. Ahmadi, K. Filipsson, et al. · Obesity Science & Practice · 14
PDF
Prevalence of primary aldosteronism among patients with type 2 diabetes
2017 · Mauro Tancredi, Gudmundur Johannsson, et al. · Clinical Endocrinology · 14
Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial)
2014 · Marcus Lind, Irl B. Hirsch, et al. · Primary care diabetes · 13
Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With Multiple Daily Insulin Injections: An Analysis Based on the GOLD Randomized Trial (GOLD 8)
2022 · Thomas Nyström, Erik Schwarz, et al. · Journal of Diabetes Science and Technology · 11
PDF
Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections
2021 · Klara Westman, Henrik Imberg, et al. · Journal of Diabetes and its Complications · 2
The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)
2020 · Shilan Seyed Ahmadi, Klara Westman, et al. · 2
Works count: 33
Citation count: 3,659
H-index: 18
I10-index: 23
Year
Topic
Type